Current Hematologic Malignancy Reports

Papers
(The H4-Index of Current Hematologic Malignancy Reports is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations78
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions36
Monoclonal Gammopathy-Associated Neuropathy26
Management of Chronic Myeloid Leukemia in Children and Young Adults22
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations22
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease17
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications17
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities17
Challenges in Chronic Myeloid Leukemia Management in South America14
Treatment-Free Remission: the New Goal in CML Therapy13
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer12
Transplantation and Cellular Therapy for Older Adults—The MSK Approach12
Value in Myeloma Care: Myth or Reality12
Targeting Apoptosis in ALL12
0.016692876815796